01- How To De-Escalate Prasugrel After Acute Coronary Syndrome?
Patients who undergo coronary angioplasty after acute coronary syndrome could de-escalate dual antiplatelet therapy with prasugrel to maintain the protection against ischemic events while lowering their hemorrhagic risk.
Read more HERE
02- Not All Coronary Spasms Are the Same: Benefits of Acetylcholine
Patients with documented spasm to the coronary arteries present increased risk of myocardial infarction (MI) and repeat angiography, while patients with microvascular spasm are associated to recurrent angina.
Read more HERE
03- What Is the Healthiest Diet?
This review published in JACC focuses on the foods we shood consume rather than the foods we should avoid eating (the latter being the most common focus).
Read more HERE
04- Post TAVR ASA Monotherapy Consolidates
This meta-analysis to be published in J Am Cardiol supports the use of aspirin monotherapy (ASA) after transcatheter aortic valve replacement (TAVR).
Read more HERE
05- Efficacy of Remdesivir against COVID-19
This final report published in NEJM about the efficacy of remdesivir against COVID-19 infection vs placebo showed its superiority though only in soft end points, which does not seem to modify the course of this pandemic.
Read more HERE
06- Further Evidence in Favor of Non-Invasive Vasospasm Diagnosis
Non-invasive coronary vasospasm diagnosis by means of echocardiography with the administration of ergonovine can be performed safely; even without prior angiography to rule out fixed lesions.
Read more HERE
07- Long-Term Cardiovascular Effects of COVID-19
In many places worldwide, the worst part of the pandemic is still to come. Meanwhile, in other areas, the number of cases is rising again. In this context, the long-term effects of COVID-19 are starting to show.
Read more HERE
08- Conscious Versus General Anesthesia in TAVR
Patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) can safely undergo the procedure under conscious sedation.
Read more HERE
09- TCT 2020 | Initial Studies Show Incredible Results with Lithotripsy in Calcified Lesions
Intravascular coronary lithotripsy shows promise for the improvement of angioplasty in severely calcified lesions, according to data from the DISRUPT CAD III study, published in JACC and simultaneously presented at the TCT 2020 Congress.
Read more HERE
10- Diabetes Could Decide between Ticagrelor and Prasugrel
Diabetes has an impact on the relative effect of ticagrelor and prasugrel in patients undergoing acute coronary syndrome (ACS) according to a recent analysis of the ISAR-REACT 5 published in JACC Intv.
Read more HERE
Subscribe to our weekly newsletter
Get the latest scientific articles on interventional cardiology
